ANAB
AnaptysBio, Inc. · Healthcare
CEO Daniel Faga sold $3.4M of AnaptysBio, Inc.
Sold$3,389,452
$22.76Price
148,940Shares
−27%Stake
What ANAB did after the filing
- The stock from Wed, Mar 27 open, $14.43
- +21.2%
- S&P 500, same days
- −0.3%
Measured over 30 trading days, to the May 9 close.
Traded Fri, Mar 22. Filed Tue, Mar 26, 8:10 PM ET, after the close. Returns use the Mar 27 open and the May 9 close. Not investment advice.